Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma

Lung cancer is responsible for 2.21 million annual cancer cases and is the leading worldwide cause of cancer-related deaths. Specifically, lung adenocarcinoma (LUAD) is the most prevalent lung cancer subtype resulting from genetic causes; LUAD has a 15% patient survival rate due to it commonly being...

Full description

Bibliographic Details

Published in:	Biomolecules
Main Authors:	Sanjan S. Sarang, Catherine M. Cahill, Jack T. Rogers
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Subjects:	lung adenocarcinoma differential gene expression multiomics protein–protein interactions early-stage markers
Online Access:	https://www.mdpi.com/2218-273X/15/6/803